Search
Now showing items 51-60 of 1797
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia
Krober, A et al. (2006)
Wissenschaftlicher Artikel
V-H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
Krober, A et al. (2002)
Wissenschaftlicher Artikel
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination moth all-trans retinoic acid in patients with acute myeloid leukemia
Kuendgen, A et al. (2006)
Wissenschaftlicher Artikel
Cancer vaccines for patients with acute myeloid leukemia - defintion of leukemia-associated antigens and current clinical protocols targeting these antigens
Greiner, Jochen; Döhner, Hartmut; Schmitt, Michael (2006)
Wissenschaftlicher Artikel
Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias
Krauter, J et al. (2003)
Wissenschaftlicher Artikel
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes
Korz, C et al. (2002)
Wissenschaftlicher Artikel
Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia
Schlenk, Richard F.; Döhner, Hartmut (2013)
Wissenschaftlicher Artikel
Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia - Reply
Kroeber, Alexander; Döhner, Hartmut; Stilgenbauer, Stephan (2006)
Wissenschaftlicher Artikel
MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia
Krowiorz, K. et al. (2016)
Wissenschaftlicher Artikel
Genome-wide genotyping of acute myeloid leukemia with translocation t(9;11)(p22;q23) reveals novel recurrent genomic alterations
Kuehn, Michael W. M. et al. (2014)
Wissenschaftlicher Artikel